Bill

Bill > HB1644


TX HB1644

TX HB1644
Relating to the use, possession, delivery, or manufacture of testing equipment that identifies the presence of a substance listed in Penalty Group 1-B or xylazine.


summary

Introduced
12/17/2024
In Committee
04/24/2025
Crossed Over
04/23/2025
Passed
Dead
06/02/2025

Introduced Session

89th Legislature Regular Session

Bill Summary

AN ACT relating to the use, possession, delivery, or manufacture of testing equipment that identifies the presence of a substance listed in Penalty Group 1-B or xylazine.

AI Summary

This bill amends the Texas Health and Safety Code to create an exception to existing drug-related laws by explicitly allowing the use, possession, delivery, or manufacture of testing equipment designed to identify substances in Penalty Group 1-B or xylazine. Penalty Group 1-B typically includes substances like heroin and other opioids, while xylazine is a veterinary sedative that has increasingly been found in the illicit drug supply. The bill essentially provides legal protection for individuals who possess or use drug testing equipment, which could be interpreted as a harm reduction measure aimed at helping people identify potentially dangerous substances and prevent overdoses. The changes will apply only to offenses committed on or after September 1, 2025, and will not retroactively affect previous offenses. By creating this legal exception, the bill appears to support efforts to reduce drug-related harm by enabling safer substance identification methods without criminal penalties.

Committee Categories

Health and Social Services, Justice

Sponsors (10)

Last Action

Referred to Criminal Justice (on 04/24/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...